Anaemia of prematurity: Epidemiology, management and costs

PharmacoEconomics

Volumn 12, Issue 4, 1997, Pages 438-445

  Meyer, Michael P ^a  

^a MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLOOD TRANSFUSION; COST BENEFIT ANALYSIS; HUMAN; IRON DEFICIENCY; NEWBORN; NEWBORN INTENSIVE CARE; PREMATURITY; PRIORITY JOURNAL; REVIEW; SUDDEN INFANT DEATH SYNDROME;

EID: 0030770101     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199712040-00002     Document Type: Review

References (35)

1. Strauss RG. Erythropoietin and neonatal anemia. N Engl J Med 1994; 330: 1227-8
2. Ohls RK, Osborne KA, Christensen RD. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized placebo-controlled trial. J Pediatr 1995; 126: 421-6
3. Shannon KM, Keith JF, Mentzer WC, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyle transfusions in very low birth weight preterm infants. Pediatrics 1995; 95: 1-8
4. Strauss RG. Erythropoietin in the pathngencsis and treatment ot neonatal anemia. Trans fusion 1995; 35: 68-73
5. Gallagher PG. Ehrenkranz RA. Erythropoietin therapy for anemia of prematurity. Clin Perinatol 1993; 20: 169-91
6. Ohls RK, Christensen RD. Recombinant erthropoietin com pared with enthrocylc transfusion in the anemia of prematurity. J Pediatr 1991; 119: 781-8
7. Shannon KM, Naylor G, Torkildson JC, et al. Circulating erythroid progenitors in the anemia of prematurity. N J Engl J Med 1987; 317: 728-33
8. Rhondeau SM, Christensen RD, Ross MP, et al. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with 'anemia of prematurity'. J Pediatr 1988; 112: 935-40
9. Kinmond S, Aitchison TC, Holland BM, et al. Umbilical cord clamping and preterm infants: a randomized trial. BMJ 1993; 306: 172-5
10. Bechensteen AG, Haga P, Halvorsen S, el al. Erythropoictin, protein, and iron supplementation and the prevention of the anaemia of prematurity. Arch Dis Child 1993; 69: 19-23
11. Brown MS, Shapiro H, Effect of protein intake on crythropoiesis during crythropoictin treatment of anemia of prematurity. J Pediatr 1996; 128: 512-7
12. Blajchman MA. Transfusion-associated bacterial sepsis: the phoenix rises yet again. Transfusion 1994; 34: 940-2
13. Yu VYH, Gan TE. Red cell transfusion in the preterm infant. J Pediatr Child Health 1994; 30: 301-9
14. Gilbert GL, Hayes K, Hudson I, et al. Prevention transfusion-acquired cytomegalovirus infection in infants by blood fillration to remove leneoeytes. Lancet 1989; 1: 1228-31
15. 5. Voak D, Garni R, Linney RD, et al. Guidelines tor administration ol blood products: transfusion ol infants and neonates. Transfus Med 1994; 4: 63-9
16. Meyer MP, Meyer JH, Commerford A, el al. Recombinant human crythropoietin in the treatment of the anemia of prematurily: results of a double-blind placebo-controlled study. Pediatrics 1994; 93: 918-23
17. Widness JA, Seward VJ, Kroiner IJ, el al. Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr 1996: 129: 680-7
18. Miyake T, Kung CK. Goldwasser E. Purification of human erythropoietin. J Biol Chem 1977; 252: 2633-8
19. Jacobs K, Shoemaker C, Rudersdorf R, et al. Isolation and characterisation of genomic and cDNA clones of human erythropoietin. Nature 1985; 313: 806-10
20. Lin F-K, Suggs S, Lin C, et al. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 1985; 82: 7580-4
21. Brown MS, Jones MA, Ohls RK, et al. Single-dose pharmaeokinetics of recobinant human erythropoietin in preterm infants alter intravenous and subcutaneous administration. J Pediatr 1992; 122: 655-7
22. Shannon K. Recombinant erythropoietin in anemia ot prematurity: five years later. Pediatrics 1993; 92: 614-6
23. Maier RF, Oblmlen M, Scignlla P, et al. the effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight Infants. N Engl J Med 1994; 330: 1173-8
24. Ohls RK, Veerman MW, Christensen RD. Pharmacokinctics and effectiveness of recombinint crythropoietin administered to preterm infants by continuous infusion in total patenteral nutrition solution. J Pediatr 1996: 128: 518-23
25. Messer J, Haddad J, Donalo L, et al. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1993; 92: 519-23
26. Sonbasi V, Kremenopoulos G, Diamandi E, et al. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study. Pediatr Res 1993; 34: 675-9
27. Shannon K, Mentzer WC, Abels RI, et al. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study J Pediatr 1991; 118: 949-55
28. Meyer MP, Haworth C, Meyer JH, et al. A comparison of oral and intravenons iron supplementation in prelerm infants receiving recomhinanl erythropoielin. J Pediatr 1996: 129: 258-63
29. Christensen RO, Koenig J, Viscochil DH, et al. Down-modulation ol neulrophil production by erythropoielin in human hematopoietic clones. Blood 1989; 74: 817-22
30. Emmerson AJB, Coles HJ, Stein CMM, et al. Double-blind mal of recombinant human crythropoietin in preterm inlants. Arch Dis Child 1993; 68: 291-6
31. Meyer MP, Haworlh C, McNeill L. Is the use of recombinant human erythropoietin in anemia ot prematurity cost-effective? S Air Med J 1996; 86: 251-3
32. Messer J, Schiffer F, Donato L, et al. Which infanls are the best candidates for treatment with rh erythropoielin (rh EPO) in anemia of prematurity. [abstract]. Pediatr Res 1994; 35: 241A
33. Al-Kharfy T, Smyth JA, Wadsworth L, et al. Erythropoietin therapy in neoiuilcs at risk ot having bronchopulmonary dysplasia and requiring multiple transfusions. J Pediatr 1996; 129: 89-96
34. Shireman TI, Hilsenrath PE, Strauss RG, et al. Recombinant human erythropoietin vs transfusion in the treatment ol ane- mia of prematurity. Arch Pediatr Adolesc Mod 1994; 148: 582-8
35. Holland PV. Viral infections and the blood supply Nee Engl J Mod 1996; 334: 1734-5